7th Annual USC Multi-Disciplinary Breast Cancer Symposium


 

The Role of CDK4/6 in HR+ BC: 2nd, 3rd Line and Beyond, and Single-agent Abemaciclib, and Discussion of Toxicity Profiles

58 views
January 22, 2021
Comments 0
Login to view comments. Click here to Login